Nutriband Inc. to Present at the MicroCap Rodeo Conference
Nutriband Inc. (NASDAQ:NTRB) has announced its participation in the upcoming MicroCap Rodeo Conference in New York City on September 25, 2025. Company Chairman Serguei Melnik will deliver a presentation at 10:00 AM, focusing on operational highlights, growth initiatives, and the company's AVERSA platform technology.
The presentation will be available via live webcast, and management will conduct one-on-one meetings with approved investors. Interested parties can register for the virtual presentation through the conference website at www.microcaprodeo.com.
Nutriband Inc. (NASDAQ:NTRB) ha annunciato la propria partecipazione alla prossima MicroCap Rodeo Conference a New York City il 25 settembre 2025. Il presidente della società, Serguei Melnik, terrà una presentazione alle 10:00, concentrandosi su aspetti operativi, iniziative di crescita e sulla tecnologia della piattaforma AVERSA dell'azienda. La presentazione sarà disponibile tramite webcast in diretta, e il management svolgerà incontri one-to-one con investitori approvati. Le parti interessate possono registrarsi per la presentazione virtuale tramite il sito della conferenza all'indirizzo www.microcaprodeo.com.
Nutriband Inc. (NASDAQ:NTRB) ha anunciado su participación en la próxima MicroCap Rodeo Conference en la ciudad de Nueva York el 25 de septiembre de 2025. El presidente de la empresa, Serguei Melnik, ofrecerá una presentación a las 10:00 a.m., enfocándose en los aspectos operativos, las iniciativas de crecimiento y la tecnología de la plataforma AVERSA de la empresa. La presentación estará disponible vía webcast en vivo, y la dirección llevará a cabo reuniones uno a uno con inversores aprobados. Las personas interesadas pueden registrarse para la presentación virtual a través del sitio web de la conferencia en www.microcaprodeo.com.
Nutriband Inc. (NASDAQ:NTRB)은 다가오는 뉴욕시 마이크로캡 로데오 컨퍼런스에 2025년 9월 25일 참가를 발표했습니다. 회사 의장 Serguei Melnik가 오전 10:00에 프레젠테이션을 진행하며, 운영상의 하이라이트, 성장 전략, 그리고 회사의 AVERSA 플랫폼 기술에 중점을 둘 예정입니다. 프레젠테이션은 라이브 웹캐스트로 제공되며 경영진은 승인된 투자자들과의 1대1 면담을 진행합니다. 관심 있는 분들은 컨퍼런스 웹사이트 www.microcaprodeo.com에서 가상 프레젠테이션 등록을 할 수 있습니다.
Nutriband Inc. (NASDAQ:NTRB) a annoncé sa participation à la prochaine MicroCap Rodeo Conference à New York le 25 septembre 2025. Le président de la société, Serguei Melnik, fera une présentation à 10h00, en mettant l'accent sur les temps opérationnels, les initiatives de croissance et la technologie de la plateforme AVERSA de l'entreprise. La présentation sera disponible en webcast en direct, et la direction mènera des entretiens en tête-à-tête avec des investisseurs approuvés. Les parties intéressées peuvent s’inscrire à la présentation virtuelle via le site web de la conférence à www.microcaprodeo.com.
Nutriband Inc. (NASDAQ:NTRB) hat seine Teilnahme an der bevorstehenden MicroCap Rodeo Conference in New York City am 25. September 2025 angekündigt. Der Vorstandsvorsitzende des Unternehmens, Serguei Melnik, wird eine Präsentation um 10:00 Uhr halten und dabei auf operative Highlights, Wachstumsinitiativen und die AVERSA-Plattformtechnologie des Unternehmens eingehen. Die Präsentation wird im Live-Webcast verfügbar sein, und das Management wird Einzelgespräche mit genehmigten Investoren führen. Interessierte können sich für die virtuelle Präsentation über die Konferenzwebsite unter www.microcaprodeo.com registrieren.
Nutriband Inc. (NASDAQ:NTRB) أعلنت عن مشاركتها في مؤتمر MicroCap Rodeo المزمع عقده في مدينة نيويورك في 25 سبتمبر 2025. سيقدّم رئيس الشركة Serguei Melnik عرضاً في الساعة 10:00 صباحاً، مع التركيز على أبرز النقاط التشغيلية ومبادرات النمو وتكنولوجيا منصة AVERSA الخاصة بالشركة. سيكون العرض متاحاً عبر البث المباشر، وستجري الإدارة اجتماعات ثنائية مع المستثمرين المعتمدين. يمكن للمهتمين التسجيل للعرض الافتراضي من خلال موقع المؤتمر على www.microcaprodeo.com.
Nutriband Inc. (NASDAQ:NTRB) 已宣布将参加将于纽约市举行的 MicroCap Rodeo Conference，时间为2025年9月25日。公司董事长Serguei Melnik将于上午10:00举行演讲，重点介绍运营亮点、增长举措以及公司的 AVERSA 平台技术。该演示将提供现场网络直播，管理层将与经批准的投资者进行一对一会谈。感兴趣的方可通过大会网站 www.microcaprodeo.com 注册虚拟演示。
- None.
- None.
Thursday, September 25, 2025 in New York City
ORLANDO, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (The Company) (Nasdaq:NTRB) (Nasdaq: NTRBW), announces it will participate in the MicroCap Rodeo Conference, to be held Thursday, June 25, 2025, in New York City.
For example: Company Chairman, Serguei Melnik, will be attending the conference to discuss the company’s operational highlights, growth initiatives, and strategic direction for its platform technology AVERSA.
The presentation will be at 10AM on Thursday September 25, and will be webcast live. Interested parties can register to watch the virtual presentation. Management will also be available for one-on-one meetings with approved investors. More information and registration for the conference can be found at www.microcaprodeo.com.
About the MicroCap Rodeo Conference
The MicroCap Rodeo Conferences are unique, as they are run by money managers and investors, for money managers and investors. On September 25, 2025, the executive management teams of approximately 15 microcap companies across a wide swath of industries will participate. Investors will have the opportunity to discover unique, high-quality stock ideas for their portfolios through group presentations and one-on-one meetings. The conference will also feature industry guest speakers and ample networking opportunities throughout the event.
For more information, please contact: info@microcaprodeo.com
About Nutriband Inc.
We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
The Company’s website is www.nutriband.com. Any material contained in or derived from Company’s websites or any other website if not part of this press release.
Forward-Looking Statements
Certain statements contained in this press release, including, without limitation, statements containing the words ‘’believes,” “anticipates,” “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company’s actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company’s ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company’s business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Form S-1, Form 10-K for the year ended January, 2025, filed April 28, 2025, the Forms 10-Q’s filed subsequent to the Form 10-K in 2025, and the Company’s other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.
For more information, contact:
Nutriband Inc.
Phone: 407-377-6695
Email: info@nutriband.com
FAQ
When is Nutriband (NTRB) presenting at the MicroCap Rodeo Conference?
Who will be presenting for Nutriband (NTRB) at the MicroCap Rodeo Conference?
What topics will be covered in Nutriband's (NTRB) MicroCap Rodeo presentation?
How can investors access Nutriband's (NTRB) MicroCap Rodeo presentation?
